跳至主要内容
临床试验/EUCTR2007-004642-32-GB
EUCTR2007-004642-32-GB进行中(未招募)1 期

THE EFFECT OF THEOPHYLLINE IN PATIENTS WITH RHINITIS - Theophylline in rhinitis

niversity of East Anglia0 个研究点目标入组 27 人开始时间: 2007年11月26日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
27

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Males or females, aged between 16 and 65 years.
  • Weight between 50 and 150 Kg.
  • Smokers, non-smokers or ex-smokers
  • Chronic rhinosinusitis as defined as 2 or more symptoms of nasal blockage/congestion, discharge, facial pain or reduction in smell for more than 12 weeks.
  • A positive skin prick test or RAST to a perennial allergen
  • Patients with a seasonal component to their symptoms can be enrolled out with the relevant pollen season.
  • Patients must be receiving intranasal corticosteroids
  • Patients will be permitted to receive inhaled short and long acting beta2 agonists or anti-cholinergic drugs, inhaled corticosteroids (up to a dose of 2mg per day BPD equivalent), oral montelukast or oral antihistamines.
  • Able to provide written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Significant medical, surgical or psychiatric disease that would affect the results of the study in the opinion of the investigator.
  • Women who are pregnant or breast feeding
  • Patients with previous cardiac problems or significant renal or hepatic impairment
  • Upper respiratory tract infection in the last month as defined by yellow or green nasal discharge and increase in the usual nasal symptoms.
  • Patients consuming more than the recommended amount of alcohol (14 units per week for women and 21 units per week for men)
  • Inhaled corticosteroids at a dose greater than 2mg beclomethasone dipropionate (BDP) equivalent or oral corticosteroids or oral zafirlukast
  • Currently receiving oral theophyllines.
  • Previous adverse effects to oral or intravenous theophylline.
  • Currently any medication known to interact with theophylline including
  • oAllopurinol
  • oMacrolide, quinolone or isoniazid
  • oFluvoxamine
  • oCarbamazepine, phenytoin
  • oFluconazole or itraconazole
  • oBarbiturates
  • oOestrogens
  • oCimetidine

研究者

发起方
niversity of East Anglia

相似试验